Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Teva Pharma Industries Ltd ADR
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NYSE
IPO Date: March 26, 1990
Headquarters: 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$32.63
Near-term / short-term trend
Weekly
40-Week SMA
$28.14
Medium-term trend
Weekly
80-Week SMA
$22.66
Cyclical trend (business cycle)
Weekly
200-Week SMA
$16.02
Secular trend (multi-year)
Monthly
10-Month SMA
$28.49
Near-term monthly trend
Monthly
20-Month SMA
$22.81
Medium-term monthly trend
Monthly
40-Month SMA
$17.41
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$20.60
support
1.15x
5 months ago
$14.00
support
1.30x
23 months ago
Historical Earnings Reactions (122 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.15%
0.15%
54.92%
20.79%
-7.26%
1 Day
0.41%
0.11%
50.82%
28.37%
-13.26%
1 Week
0.90%
0.49%
52.46%
40.03%
-27.16%
2 Weeks
1.38%
1.35%
57.38%
57.30%
-27.16%
1 Month
1.33%
0.53%
57.02%
34.69%
-45.43%
Next earnings: July 29, 2026 (62 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
4.3%
56.8%
44
Feb
1.8%
52.3%
44
Mar
-0.4%
48.9%
45
Apr
1.4%
44.4%
45
May
2.0%
56.8%
44
Jun
-0.9%
45.5%
44
Jul
2.5%
47.7%
44
Aug
-1.4%
43.2%
44
Sep
1.0%
50.0%
44
Oct
-1.0%
43.2%
44
Nov
3.5%
63.6%
44
Dec
3.9%
59.1%
44
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.04%
44.9%
2106
Tuesday
0.06%
42.7%
2289
Wednesday
0.14%
46.1%
2286
Thursday
0.02%
42.1%
2244
Friday
0.07%
42.2%
2232
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 62.2%
Insider Transactions — Smart Summary
Total insider ownership: 0.0%
12-Month Insider Activity Summary
Total Filings
39
Net Value
-$80.7M
Net Shares Change
-130,522
% of Float
-0.0%
C-Suite Filings
36
Clusters Detected
4
Key Insiders
Name
Title
Net Value
Filings
Activity
Sabag Mark
Executive Vice President, International Markets Commercial
-$10.9M
3
3 sell
Daniell Richard
EVP, Europe Commercial
-$1.1M
1
1 sell
Fox Christine
EVP, U.S. Commercial
-$750,619.98
1
1 sell
Weiss Amir
Chief Accounting Officer
-$384,444
1
1 sell
Savage Brian
Interim Chief Legal Officer
-$163,759.337
3
3 sell
McAvoy David R.
EVP, Chief Legal Officer
+$20,988.064
1
1 buy
Transaction Clusters
Period
Filings
Insiders
Net Value
Seniority
2025-11-10 – 2025-11-24
4
3
-$6.6M
3 C-suite
2025-12-01 – 2025-12-11
3
3
-$6.5M
2 C-suite
2026-03-05 – 2026-03-19
17
8
-$30.3M
17 C-suite
2026-05-04 – 2026-05-18
6
6
-$14.2M
6 C-suite
Significant Filings
Date
Insider
Title
Net Value
Price After
2026-05-04
Sabag Mark
Executive Vice President, International Markets Commercial
-$5.0M
Transaction at $34.99, now -1.2%
2026-05-07
Daniell Richard
EVP, Europe Commercial
-$1.1M
Transaction at $35.40, now -2.4%
2026-05-07
Weiss Amir
Chief Accounting Officer
-$384,444
Transaction at $36.00, now -4.0%
2026-05-04
Fox Christine
EVP, U.S. Commercial
-$750,619.98
Transaction at $35.31, now -2.1%
2026-03-19
Sabag Mark
Executive Vice President, International Markets Commercial
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Teva Pharma Industries Ltd ADR
(TEVA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.